loading
Schlusskurs vom Vortag:
$0.75
Offen:
$0.75
24-Stunden-Volumen:
229.93K
Relative Volume:
0.31
Marktkapitalisierung:
$39.53M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-81.22M
KGV:
-0.2544
EPS:
-2.96
Netto-Cashflow:
$-74.41M
1W Leistung:
+6.48%
1M Leistung:
-0.32%
6M Leistung:
-9.82%
1J Leistung:
-18.15%
1-Tages-Spanne:
Value
$0.7392
$0.7594
1-Wochen-Bereich:
Value
$0.6811
$0.807
52-Wochen-Spanne:
Value
$0.615
$1.70

Xilio Therapeutics Inc Stock (XLO) Company Profile

Name
Firmenname
Xilio Therapeutics Inc
Name
Telefon
617-833-1027
Name
Adresse
828 WINTER STREET, WALTHAM
Name
Mitarbeiter
73
Name
Twitter
Name
Nächster Verdiensttermin
2025-08-08
Name
Neueste SEC-Einreichungen
Name
XLO's Discussions on Twitter

Vergleichen Sie XLO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
XLO
Xilio Therapeutics Inc
0.753 39.38M 0 -81.22M -74.41M -2.96
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.76 107.15B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
755.90 77.46B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
436.38 58.90B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
918.92 56.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
198.76 42.58B 447.02M -1.18B -906.14M -6.1812

Xilio Therapeutics Inc Stock (XLO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-06 Eingeleitet Leerink Partners Outperform
2022-12-21 Eingeleitet Chardan Capital Markets Buy
2022-01-10 Eingeleitet H.C. Wainwright Buy
2021-11-16 Eingeleitet Cowen Outperform
2021-11-16 Eingeleitet Guggenheim Buy
2021-11-16 Eingeleitet Morgan Stanley Overweight
2021-11-16 Eingeleitet Raymond James Outperform
Alle ansehen

Xilio Therapeutics Inc Aktie (XLO) Neueste Nachrichten

pulisher
Nov 21, 2025

Is Xilio Therapeutics Inc. stock a buy before product launchesJuly 2025 Rallies & Low Drawdown Momentum Ideas - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How institutional buying supports Xilio Therapeutics Inc. stockMarket Performance Report & High Accuracy Trade Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is Xilio Therapeutics Inc. stock resilient to inflationWeekly Trade Report & Low Risk High Reward Trade Ideas - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Is Xilio Therapeutics Inc a good long term investmentFundamental Stock Analysis & Free Technical Analysis and Insights - earlytimes.in

Nov 20, 2025
pulisher
Nov 20, 2025

Can Samtex Fashions Limited Outperform Index Funds Over the Next 5 YearsEmerging Market Stocks & Free Rapid Profit Acceleration - earlytimes.in

Nov 20, 2025
pulisher
Nov 20, 2025

Is ACRS a good long-term investment? - earlytimes.in

Nov 20, 2025
pulisher
Nov 19, 2025

Tick level data insight on Xilio Therapeutics Inc. volatilityGlobal Markets & Stock Timing and Entry Methods - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Xilio Therapeutics Inc. stock compares to market leadersWeekly Gains Report & High Accuracy Trade Signal Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why Xilio Therapeutics Inc. stock remains on watchlists2025 Buyback Activity & Fast Gain Swing Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Xilio Therapeutics Reports Revenue Growth Amidst Challenges - MSN

Nov 19, 2025
pulisher
Nov 19, 2025

Why Xilio Therapeutics Inc. stock is in analyst buy zoneTrade Exit Summary & Verified Entry Point Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How geopolitical tensions affect Xilio Therapeutics Inc. stock2025 Macro Impact & Daily Stock Momentum Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Xilio Therapeutics Inc. stock safe for conservative investorsJuly 2025 Highlights & Daily Stock Trend Watchlist - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is it too late to sell Xilio Therapeutics Inc.2025 Market Trends & AI Forecasted Entry and Exit Points - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is it time to cut losses on Xilio Therapeutics Inc.Portfolio Value Report & Daily Technical Stock Forecast Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 00:08:23 - newser.com

Nov 19, 2025
pulisher
Nov 17, 2025

Building trade automation scripts for Xilio Therapeutics Inc.July 2025 Review & Risk Controlled Stock Alerts - newser.com

Nov 17, 2025
pulisher
Nov 16, 2025

Tools to assess Xilio Therapeutics Inc.’s risk profileInsider Selling & Real-Time Stock Movement Alerts - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

What drives WHLRD stock priceDouble Top/Bottom Patterns & Low Risk Trading Plans - earlytimes.in

Nov 16, 2025
pulisher
Nov 16, 2025

Top Growth Drivers Behind Omnitex Industries India Limited Stocks Recent SurgeRisk Mitigation Techniques & Affordable Market Insights - earlytimes.in

Nov 16, 2025
pulisher
Nov 16, 2025

What makes Xilio Therapeutics Inc. stock attractive to growth fundsFed Meeting & Risk Managed Investment Entry Signals - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

What machine learning models say about Xilio Therapeutics Inc.July 2025 Macro Moves & Daily Growth Stock Tips - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Published on: 2025-11-15 13:28:14 - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Best data tools to analyze Xilio Therapeutics Inc. stockBreakout Watch & Weekly Chart Analysis and Guides - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Published on: 2025-11-15 00:01:21 - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

Xilio Therapeutics, Inc. (XLO) Reports Q3 Loss, Misses Revenue Estimates - sharewise.com

Nov 14, 2025
pulisher
Nov 14, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Applied Therapeutics (APLT) and Xilio Therapeutics (XLO) - The Globe and Mail

Nov 14, 2025
pulisher
Nov 13, 2025

What Fibonacci levels say about Xilio Therapeutics Inc. reboundJuly 2025 Movers & AI Optimized Trade Strategies - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

Xilio Therapeutics Banks More Revenue But Spends Heavily On Research - Finimize

Nov 13, 2025

Finanzdaten der Xilio Therapeutics Inc-Aktie (XLO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$38.92
price up icon 1.38%
$30.45
price up icon 1.36%
$102.06
price up icon 0.29%
$95.59
price down icon 1.42%
biotechnology ONC
$347.72
price down icon 0.45%
$198.76
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):